Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Paul A Bunn

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Bunn, Paul

One or more keywords matched the following items that are connected to Bunn, Paul

Item Type	Name
Academic Article	Letter: Should ineffective agents be used in combination chemotherapy?
Academic Article	Herpes zoster and small cell bronchogenic carcinoma.
Academic Article	Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer.
Academic Article	Perirectal infections in patients with small cell lung cancer.
Academic Article	Cutaneous T-cell lymphomas.
Academic Article	Controversies in the nonsurgical treatment of stage III non-small cell lung cancer.
Academic Article	Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
Academic Article	Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer.
Academic Article	Small-cell carcinoma of lung: reinduction therapy after late relapse.
Academic Article	Treatment of cutaneous T-cell lymphoma.
Academic Article	Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.
Academic Article	The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Academic Article	A study of drug-induced kinetic perturbations in the marrow of a patient with neuroblastoma.
Academic Article	A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer.
Academic Article	Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?
Academic Article	Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team.
Academic Article	New therapeutic strategies for lung cancer: biology and molecular biology come of age.
Academic Article	HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer.
Academic Article	A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.
Academic Article	Chemotherapy rather than demeclocycline for inappropriate secretion of antidiuretic hormone.
Academic Article	Current therapy of small cell lung cancer.
Academic Article	ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer.
Academic Article	Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a "biased agonist" mechanism.
Academic Article	Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Academic Article	What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer?
Academic Article	Central nervous system metastases in small cell bronchogenic carcinoma.
Academic Article	Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
Academic Article	HER2/neu expression in malignant lung tumors.
Academic Article	Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
Academic Article	Bradykinin-related compounds as new drugs for cancer and inflammation.
Academic Article	Lung cancer. Introduction.
Academic Article	Chemotherapy for elderly patients with advanced non-small-cell lung cancer.
Academic Article	Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.
Academic Article	State of the art therapy of mycosis fungoides and S?zary syndrome.
Academic Article	Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know.
Academic Article	The potential role of proteasome inhibitors in the treatment of lung cancer.
Academic Article	A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors.
Academic Article	Platinums in lung cancer: sufficient or necessary?
Academic Article	Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.
Academic Article	Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
Academic Article	HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.
Academic Article	Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.
Academic Article	Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.
Academic Article	Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
Academic Article	Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
Academic Article	Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Academic Article	Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
Academic Article	Novel therapies for non-small-cell lung cancer: a 2008 update.
Academic Article	N-(Fluorenyl-9-methoxycarbonyl)amino acid amide derivatives as a new class of anti-cancer agents.
Academic Article	Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib.
Academic Article	Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.
Academic Article	Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?
Academic Article	Advances in small cell bronchogenic carcinoma.
Academic Article	A new generation of EGFR tyrosine-kinase inhibitors in NSCLC.
Academic Article	Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.
Academic Article	Characteristics of lung cancers harboring NRAS mutations.
Academic Article	Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients.
Academic Article	Role of radiation therapy in small cell anaplastic carcinoma of the lung.
Academic Article	Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response.
Academic Article	Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy?
Academic Article	Novel agents in the treatment of lung cancer: conference summary statement.
Academic Article	Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
Academic Article	Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
Academic Article	The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Academic Article	Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists.
Academic Article	New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
Academic Article	Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.
Academic Article	Bradykinin antagonists: present progress and future prospects.
Academic Article	Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
Academic Article	Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.
Academic Article	[State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer].
Academic Article	Expression of target molecules in lung cancer: challenge for a new treatment paradigm.
Academic Article	Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Academic Article	Bradykinin antagonists as new drugs for prostate cancer.
Academic Article	Ongoing and future trials of biologic therapies in lung cancer.
Academic Article	Targeting the epidermal growth factor receptor in non-small cell lung cancer.
Academic Article	Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
Academic Article	Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
Academic Article	Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report.
Academic Article	Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.
Academic Article	Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma.
Academic Article	A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer.
Academic Article	Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer.
Academic Article	Can acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors be overcome by different small-molecule tyrosine kinase inhibitors?
Academic Article	Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations?
Academic Article	Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Academic Article	The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.
Academic Article	Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
Academic Article	EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
Academic Article	Molecularly targeted therapy: when to stop and when to continue?
Academic Article	Review of therapeutic trials of carboplatin in lung cancer.
Academic Article	ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC).
Academic Article	A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.
Academic Article	Early-stage NSCLC: the role of radiotherapy and systemic therapy.
Academic Article	Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.
Academic Article	Automated fluorescent analysis for drug-induced cytotoxicity assays.
Concept	Antineoplastic Agents
Concept	Antineoplastic Agents, Phytogenic
Academic Article	Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.
Academic Article	Improving the Care of Patients With Stage IB Non-Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.
Academic Article	Adjuvant TKIs in NSCLC: what can we learn from RADIANT?
Academic Article	New and emerging targeted treatments in advanced non-small-cell lung cancer.
Academic Article	Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.
Academic Article	Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal?from the Bench.
Academic Article	Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer.
Academic Article	The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
Academic Article	Eribulin inhibits the growth of small cell lung cancer cell lines alone and with radiotherapy.
Academic Article	Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP).
Academic Article	Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Academic Article	The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.
Academic Article	Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.
Concept	Antineoplastic Agents, Immunological
Academic Article	CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.

Search Criteria

Antineoplastic Agents